content_image/158377.jpg
## Bayport Butyllithium Shutdown 

In March 2009, we made the decision to close our Bayport butyllithium facility located in Bayport, Texas. The Bayport butyllithium facility is part of our Lithium division. Our decision is consistent with our ongoing strategy to be globally competitive and focus on products consistent with market demands. 

## Bromborough Lithium Metal Production Shutdown 

In September 2009, we made the decision to close our Lithium metal production unit at our Bromborough, UK plant. The facility is included in our Specialty Chemicals segment. 

## Industrial Chemicals 

## Huelva Shutdown 

In November 2010, we made the decision to cease operations at our Huelva, Spain facility and exit the phosphate business in Europe. Th  e facility was a part of our subsidiary FMC Foret, S.A. (“Foret”), which is included in our Industrial Chemicals segment. The closure of the facility was initiated as a consequence of the Spanish judicial ruling which, effective January 1, 2011, prohibited us from storing phosphogypsum on a site adjacent to our production facility. The phosphogypsum is a byproduct of the process of manufacturing phosphoric acid, which is used in the manufacturing of our phosphate products. After receipt of the unfavorable Spanish judicial ruling, we attempted to pursue strategic alternatives for our Foret phosphorus business. With no reasonable economic alternatives, the judicial ruling inhibited our ability to cost effectively produce our phosphate product and therefore rendered it uneconomical for FMC to continue operations at the facility. We ceased production at this facility as of December 31, 2010. 

## Rollforward of Restructuring Reserves 

## Barcelona Facility Shutdown 

In June 2009, we made the decision to phase out operations of our Barcelona, Spain, which was completed in 2010. The facility is part of Foret. High costs at the Barcelona facility coupled with reduced demand for product manufactured at that site had made it uneconomical for FMC to continue operations at the Barcelona facility. 

## Santa Clara Shutdown 

In March 2009, we made the decision to shut down our manufacturing operations at our Peroxygens facility in Santa Clara, Mexico. Th  e decision to shut down the Santa Clara operations was made in an eff ort to maximize cost savings and improve efficiencies. 

## Other Items 

In addition to the restructurings described above, we engaged in certain other restructuring activities during the years ended December 31, 2010, 2009 and 2008, which resulted in severance and asset disposal costs. We expect these restructuring charges to improve our global competitiveness through improved cost efficiencies. 

For the year ended December 31, 2010, we recorded $4.8 million of charges, of which $0.6 million, $0.2 million and $4.0 million were related to Agricultural Products, Specialty Chemicals and Industrial Chemicals, respectively. For the year ended December 31, 2009, we recorded $19.0 million of charges, of which $2.6 million, $2.5 million and $13.9 million were related to Agricultural Products, Specialty Chemicals and Industrial Chemicals, respectively. For the year ended December 31, 2008, we recorded $15.1 million of charges, of which $5.4 million, $4.0 million and $5.7 million were related to Agricultural Products, Specialty Chemicals and Industrial Chemicals segments, respectively. 

The following table shows a rollforward of restructuring reserves that will result in cash spending. These amounts exclude asset retirement obligations, which are discussed in Note 8. 

<img src='content_image/158377.jpg'>

(1) Primarily severance costs related to workforce reductions and facility shutdowns described in the “Other Items” sections above. 

(2) Primarily severance costs and in the Alginates Restructuring row in 2010, the accrual of costs associated with leased properties which we have ceased using. The asset disposal charges noted above impacted our property, plant and equipment balances and are not included in the above tables. 

(3) Included in “Accrued and other liabilities” and “Other long-term liabilities” on the consolidated balance sheets. 

(4) Primarily includes foreign currency translation adjustments. 

